Advertisement

Advertisement

ETON Stock Latest News

Eton Pharmaceuticals: Buy Rating Reiterated as Strategic IMPAVIDO Deal Supports Asset-Light Growth and Unchanged $57 Price Target

RatingsEton Pharmaceuticals: Buy Rating Reiterated as Strategic IMPAVIDO Deal Supports Asset-Light Growth and Unchanged $57 Price Target

Eton Pharmaceuticals Signals Strong Momentum in Earnings Call

PremiumCompany Announcements

Eton Pharmaceuticals Signals Strong Momentum in Earnings Call

7d ago

Eton Pharmaceuticals Secures U.S. Rights to IMPAVIDO

PremiumCompany Announcements

Eton Pharmaceuticals Secures U.S. Rights to IMPAVIDO

7d ago

Eton Pharmaceuticals enters supply, distribution agreement for Impavido

PremiumThe Fly

Eton Pharmaceuticals enters supply, distribution agreement for Impavido

7d ago

Eton Pharmaceuticals Signals Strong Momentum In Earnings

PremiumCompany Announcements

Eton Pharmaceuticals Signals Strong Momentum In Earnings

11d ago

Eton Pharmaceuticals price target raised to $57 from $52 at H.C. Wainwright

PremiumThe FlyEton Pharmaceuticals price target raised to $57 from $52 at H.C. Wainwright

11d ago

ETON Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

ETON Earnings Report this Week: Is It a Buy, Ahead of Earnings?

15d ago

Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

Company Announcements

Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

25d ago

Eton Pharmaceuticals announces relaunch of Hemangeol

PremiumThe Fly

Eton Pharmaceuticals announces relaunch of Hemangeol

26d ago

Eton Starts Pilot Trial of ET-700 for Wilson Disease

PremiumCompany Announcements

Eton Starts Pilot Trial of ET-700 for Wilson Disease

30d ago

Eton Pharmaceuticals says first patient dosed in study of ET-700

PremiumThe Fly

Eton Pharmaceuticals says first patient dosed in study of ET-700

30d ago

Eton Pharmaceuticals Announces New Chief Financial Officer Appointment

PremiumCompany Announcements

Eton Pharmaceuticals Announces New Chief Financial Officer Appointment

1M ago

Eton Pharmaceuticals appoints Judith Matthews as CFO

PremiumThe FlyEton Pharmaceuticals appoints Judith Matthews as CFO

1M ago

Eton Pharmaceuticals Amends Credit Agreement, Eases Debt Terms

Company Announcements

Eton Pharmaceuticals Amends Credit Agreement, Eases Debt Terms

1M ago

Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path

Company Announcements

Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path

2M ago

Eton Pharmaceuticals price target raised to $52 from $37 at H.C. Wainwright

PremiumThe Fly

Eton Pharmaceuticals price target raised to $52 from $37 at H.C. Wainwright

2M ago

Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target

PremiumRatings

Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target

2M ago

Eton Pharmaceuticals price target raised to $35 from $30 at Craig-Hallum

PremiumThe Fly

Eton Pharmaceuticals price target raised to $35 from $30 at Craig-Hallum

2M ago

Eton Pharmaceuticals price target raised to $31 from $26 at B. Riley

PremiumThe Fly

Eton Pharmaceuticals price target raised to $31 from $26 at B. Riley

2M ago

Eton Pharmaceuticals reports Q4 EPS 5c vs. (2c) last year

PremiumThe FlyEton Pharmaceuticals reports Q4 EPS 5c vs. (2c) last year

2M ago

Eton Pharmaceuticals sees FY26 revenue at least $110M, consensus $105.25M

The Fly

Eton Pharmaceuticals sees FY26 revenue at least $110M, consensus $105.25M

2M ago

Is ETON a Buy, Before Earnings?

Pre-Earnings

Is ETON a Buy, Before Earnings?

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >